Opportunities for Healthy Volunteers
Contribute to medical research by participating in studies designed for healthy participants in your selected area.
↓
Matched clinical trials
A study of navenibart for long-term safety in patients with hereditary angioedema
Recruiting
Investigated Drugs:
+5
Long‑Term Safety Study of ADX‑324 in Participants with Hereditary Angioedema (Phase 3 Extension)
Not yet recruiting
Investigated Drugs:
+5
Study of Navenibart to prevent attacks in adults and adolescents with Hereditary Angioedema
Not recruiting
Investigated Diseases:Investigated Drugs:
+5
Safety Study of Switching from Current Treatment to Garadacimab in Patients Age 12 and Older with Hereditary Angioedema
Not recruiting
Investigated Drugs:
